Search - tctmd.com

Displaying 921 - 940 of 1053

Sort: Relevancy | Date

News Conference News TCT 2013

DUTCH PEERS: Third-Generation Stents Equivalent, Effective

October 31, 2013

Presentation TCT 2013

Novel Coronary Interventions

Presenter: David Moliterno

October 30, 2013

Presentation TCT 2013

TCT-126. First-in-human experience with a novel high-flow percutaneous heart pump

Presenter: David Kandzari

October 30, 2013

Presentation TCT 2013

TCT-124. A novel appliance for transcatheter mitral cerclage annuloplasty

Presenter: June-Hong Kim

October 30, 2013

Presentation TCT 2013

Novel Biomarkers and Optimal Hydration Regimens to Prevent Contrast Nephropathy

Presenter: Carlo Briguori

October 30, 2013

News Conference News TCT 2013

Novel Ischemia Measurement Strategies Show Potential vs. FFR

October 30, 2013

News Conference News TCT 2013

Need, Potential Exist for Global Integrated Regulatory Approach in Cardiology

October 30, 2013

News Conference News TCT 2013

EUROMAX: Prehospital Bivalirudin Reduces Bleeding in STEMI

October 30, 2013

News Conference News TCT 2013

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

October 30, 2013

Presentation TCT 2013

TCT-75. Novel Fully-Quantitative Virtual Histology Analysis of Confluent Necrotic Core Size and Fibrous Cap Thickness in Relation to Conventional Phenotypic Plaque Type Assessme...

Presenter: Piotr Musialek

October 29, 2013

Presentation TCT 2013

Patients Receiving Novel Agents in Whom Life Threatening Bleeding: Practical Recommendations

Presenter: Christopher Granger

October 29, 2013

Presentation TCT 2013

Early Vascular Restoration following treatment of single de-novo coronary artery lesions with the DESolve Nx Novolimus Eluting Bioresorbable Coronary Scaffold System (NEBCSS) at 6 months: Insights...

Presenter: J. Ribamar Costa Jr.

October 29, 2013

Presentation TCT 2013

TCT-69. Safety and clinical performance of the drug eluting Orsiro stent in patients with single de novo coronary artery lesions – II (BIOFLOW-II) -A quantitative analysis by IV...

Presenter: Thierry Lefevre

October 29, 2013

Presentation TCT 2013

TCT-37. Prospective, Multi-Center Evaluation of the DESolve Nx Novolimus-Eluting Bioresorbable Coronary Scaffold: First Report of One Year Clinical and Imaging Outcomes

Presenter: Martin Leon

October 29, 2013

Presentation TCT 2013

TCT-20. Two-Year Clinical Follow-Up of the FIREHAWK Abluminal Groove-Filled Biodegradable Polymer Sirolimus-Eluting Stent in the Treatment of Patients with De Novo Native Corona...

Presenter: Yelin Zhao

October 29, 2013

Presentation TCT 2013

TCT-106. Novel Hemodynamic Index for the Assessment of Aortic Regurgitation After Transcatheter Aortic Valve Replacement

Presenter: Baris Bugan

October 29, 2013

Presentation TCT 2013

Safety and Clinical Performance of the Drug Eluting Orsiro Stent in the Treatment of Subjects With Single De Novo Coronary Artery Lesions-II (BIOFLOW-II)

Presenter: Stephan Windecker

October 29, 2013

Presentation TCT 2013

All Novel Agents are Preferred to Warfarin

Presenter: Michael Ezekowitz

October 29, 2013

News Conference News TCT 2013

Paclitaxel-Coated Balloons Show Promise in Two Studies

October 29, 2013

News Conference News TCT 2013

Novel Device Demonstrates Promise for Percutaneous PDA Closure in Children

October 29, 2013

Advertisement

DUTCH PEERS: Third-Generation Stents Equivalent, Effective

Novel Coronary Interventions

TCT-126. First-in-human experience with a novel high-flow percutaneous heart pump

TCT-124. A novel appliance for transcatheter mitral cerclage annuloplasty

Novel Biomarkers and Optimal Hydration Regimens to Prevent Contrast Nephropathy

Novel Ischemia Measurement Strategies Show Potential vs. FFR

Need, Potential Exist for Global Integrated Regulatory Approach in Cardiology

EUROMAX: Prehospital Bivalirudin Reduces Bleeding in STEMI

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

TCT-75. Novel Fully-Quantitative Virtual Histology Analysis of Confluent Necrotic Core Size and Fibrous Cap Thickness in Relation to Conventional Phenotypic Plaque Type Assessme...

Patients Receiving Novel Agents in Whom Life Threatening Bleeding: Practical Recommendations

Early Vascular Restoration following treatment of single de-novo coronary artery lesions with the DESolve Nx Novolimus Eluting Bioresorbable Coronary Scaffold System (NEBCSS) at 6 months: Insights...

TCT-69. Safety and clinical performance of the drug eluting Orsiro stent in patients with single de novo coronary artery lesions – II (BIOFLOW-II) -A quantitative analysis by IV...

TCT-37. Prospective, Multi-Center Evaluation of the DESolve Nx Novolimus-Eluting Bioresorbable Coronary Scaffold: First Report of One Year Clinical and Imaging Outcomes

TCT-20. Two-Year Clinical Follow-Up of the FIREHAWK Abluminal Groove-Filled Biodegradable Polymer Sirolimus-Eluting Stent in the Treatment of Patients with De Novo Native Corona...

TCT-106. Novel Hemodynamic Index for the Assessment of Aortic Regurgitation After Transcatheter Aortic Valve Replacement

Safety and Clinical Performance of the Drug Eluting Orsiro Stent in the Treatment of Subjects With Single De Novo Coronary Artery Lesions-II (BIOFLOW-II)

All Novel Agents are Preferred to Warfarin

Paclitaxel-Coated Balloons Show Promise in Two Studies

Novel Device Demonstrates Promise for Percutaneous PDA Closure in Children

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content